Articles tagged "Pediatric"

2017 American Transplant Congress
Racial and Ethnic Disparities in Renal Replacement Therapy in Pediatric and Young Adult Population with End Stage Renal Disease (2005-2015).
R. George,¹ M. Basu,² L. Greenbaum,¹ A. Kirk,^2,3 N. Kutner,⁴ R. Patzer.^2,5
¹Pediatric Nephrology, Emory University, Atlanta, GA; ²Dept of Surgery, Emory University, Atlanta, GA; ³Dept of Surgery, Duke University, Durham, NC; ⁴USRDS Rehabilitation, QoL Special Studies Center, Atlanta, GA; ⁵Dept of Epidemiology, Rollins School of Public Health, Atlanta, GA
In the last decade, few studies have examined racial/ethnic disparities in the choice of renal replacement therapy (RRT) among children with End Stage Renal Disease…
2017 American Transplant Congress
Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers.
B. Scully,¹ J. Heinle,¹ M. Kueht,¹ E. McKenzie,¹ G. Mallory,² E. Melicoff,² A. Rana.¹
¹Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX; ²Department of Pediatrics and Pulmonology, Baylor College of Medicine, Houston, TX
PurposeLow case volume has been associated with lower survival after pediatric lung transplantation. In addition, pediatric lung retransplantation has been associated with low overall survival…
2017 American Transplant Congress
Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.
R. Hendrickson, M. Davis, A. Sherman, W. Andrews, J. Daniel, R. Fischer, D. Blowey.
Transplant Surgery, Health Services and Outcomes Research, Hepatology, and Nephrology, Children's Mercy Hospital, Kansas City, MO
BACKGROUND: Hypertension (HTN) occurs after solid organ transplant and may have an impact on future cardiovascular disease and associated co-morbidities. Little has been reported on…
2017 American Transplant Congress
Longer Ischemic Time Is Associated with Late Graft Dysfunction in Pediatric Heart Transplant Recipients.
L. Schroeder,¹ S. Chowdhury,¹ A. Burnette,¹ H. Baker,¹ A. Savage,¹ A. Atz,¹ R. Butts.²
¹Medical University of South Carolina, Charleston, SC; ²UT Southwestern, Dallas, TX
Introduction: The purpose of this study was to investigate associations between clinical factors and cardiac function as measured by pressure-volume loops (PVL) in a pediatric…
2017 American Transplant Congress
Pediatric Recipients of Deceased Adult Donor Kidneys Have Equivalent Outcomes Compared with Pediatric Donors.
D. Mikhail,¹ H. Sharma,^3,4 J. Chen,² M. Cooper,⁴ A. Sener,^1,3 P. Luke.^1,3
¹Urology, Western University, London, ON, Canada; ²Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; ³Multi-Organ Transplant Surgery, Western University, London, ON, Canada; ⁴Transplant Surgery, Georgetown University, Washington, DC
INTRODUCTION:Efforts are made to transplant paediatric deceased donor kidneys into pediatric recipients. To our knowledge, data does not support better graft outcomes with matched pediatric…
2017 American Transplant Congress
Primary Graft Dysfunction After Pediatric Heart Transplant.
K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.
Pediatric Cardiology, Washington University School of Medicine, St. Louis, MO
Background: Primary graft dysfunction (PGD), as defined by ISHLT Consensus Guidelines, has been associated with worse outcomes in adult heart transplant recipients, even in patients…
2017 American Transplant Congress
A Pilot Test of the "Individualized Self-Management Training in Adolescent/Young Adult Recipients of Transplantation (iSTART)" Program.
E. Fredericks, S. Eder, D. Egleston, W. Newhouse, D. O'Reilly, G. Freed, J. Magee, K. Resnicow.
University of Michigan, Ann Arbor
Objective: To pilot test the feasibility and impact of the iSTART program on medication adherence, quality of life, and medication barriers among adolescent/young adult (AYA)…
2017 American Transplant Congress
Alemtuzumab Use in a Single Center Pediatric Heart Transplant Cohort.
J. Case,¹ J. Eshelman,² P. Booker,² S. Miyamoto,³ M. Everitt,³ S. Auerbach.³
¹University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO; ²Pharmacy, Children's Hospital Colorado, Aurora, CO; ³Pediatrics, Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO
Purpose: To describe the use and complications of alemtuzumab (AMB), a CD52 monoclonal antibody, in pediatric heart transplant (HT) patients (pt).Methods: Retrospective chart review of…
2017 American Transplant Congress
Intraoperative Fluid Management During Pediatric Kidney Transplantation with Less Than 15kg Body Weight Using Transesophageal Echocardiaography as Hemodynamic Parameter.
Y. Watarai,¹ S. Narumi,¹ R. Kimura,¹ K. Hatazoe,¹ M. Okada,¹ K. Futamura,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ Y. Goto.²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan; ²Pediatric Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
Introduction: To avoid low output syndrome (LOS) and delayed graft function (DGF), precise intraoperative hemodynamic monitoring are mandatory for small pediatric recipients with adults' donor…
2017 American Transplant Congress
The TAKE-IT Intervention Improves Medication Adherence in Adolescent Kidney Transplant Recipients.
B. Foster,¹ A. Pai,² S. Furth,³ TAKE-IT Investigators.
¹McGill University, Montreal, Canada; ²Cincinnati Children's Hospital Medical Center, Cincinnati; ³Children's Hospital of Philadelphia, Philadelphia
Poor adherence to immunosuppressive medications limits renal allograft survival. This randomized controlled trial, evaluated whether young kidney transplant recipients administered a behavioral intervention showed greater…